Azar Nickavar
*1 Department of Pediatric Nephrology, Iran University of Medical Sciences, Tehran, Iran
*Corresponding Author: *Corresponding author: Azar Nickavar, Department of Pediatric Nephrology, Iran University of Medical Sciences, Tehran, Iran., Email:
anickavar@yahoo.com
Implication for health policy/practice/research/medical education:
Henoch-Schönlein purpura (HSP) is the most common small vessel vasculitis in children and
adolescents with high incidence of renal involvement. Delayed and inappropriate management
of severe Henoch-Schönlein nephritis is a major cause of chronic kidney disease. The
most recent treatments of Henoch-Schönlein nephritis have been discussed in this editorial
article.
Please cite this paper as: Nickavar A. Treatment of Henoch Schonlein nephritis; new trends. J
Nephropathol. 2016;5(4):116-117. DOI: 10.15171/jnp.2016.21.